Towa Pharmaceutical Co., Ltd.
4553.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥18,986 | ¥16,173 | ¥4,605 | ¥22,246 |
| Dep. & Amort. | ¥20,099 | ¥17,888 | ¥19,409 | ¥10,954 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥10,530 | -¥26,944 | -¥13,747 | -¥3,102 |
| Other Non-Cash | -¥5,154 | ¥1,095 | -¥7,723 | -¥7,969 |
| Operating Cash Flow | ¥23,401 | ¥8,212 | ¥2,544 | ¥22,129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥31,223 | -¥37,851 | -¥30,469 | -¥13,576 |
| Net Acquisitions | ¥9 | -¥1,570 | -¥1,484 | -¥45,405 |
| Inv. Purchases | -¥203 | -¥50 | -¥301 | -¥1 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥34 | ¥18 |
| Other Inv. Act. | ¥130 | -¥923 | ¥1,936 | -¥765 |
| Investing Cash Flow | -¥31,287 | -¥40,394 | -¥30,284 | -¥59,729 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥24,497 | ¥38,560 | ¥20,883 | ¥49,114 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥21 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥2,953 | -¥2,952 | -¥3,100 | -¥2,411 |
| Other Fin. Act. | ¥23 | -¥201 | -¥302 | -¥184 |
| Financing Cash Flow | ¥21,567 | ¥35,407 | ¥17,481 | ¥46,540 |
| Forex Effect | ¥1,916 | ¥2,167 | ¥1,685 | ¥975 |
| Net Chg. in Cash | ¥15,810 | ¥5,393 | -¥8,573 | ¥9,915 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥29,650 | ¥24,257 | ¥32,830 | ¥22,915 |
| End Cash | ¥45,471 | ¥29,650 | ¥24,257 | ¥32,830 |
| Free Cash Flow | -¥5,335 | -¥31,113 | -¥27,925 | ¥8,553 |